获得性免疫缺陷综合征患者的结核病诊疗进展  

Diagnosis and treatment for mycobacterium tuberculosis in human immunodeficiency virus-infected patients

作　　者：张云智[1] 卢洪洲[1,2,3] 

机构地区：[1]复旦大学附属公共卫生临床中心感染科,上海201508 [2]复旦大学附属华山医院感染科,上海200040 [3]复旦大学上海医学院内科学系,上海200032

出　　处：《世界临床药物》2010年第6期339-342,共4页World Clinical Drug

基　　金："艾滋病和病毒性肝炎等重大传染病防治"科技重大专项(2008ZX10001-008)

摘　　要：结核分枝杆菌感染是人免疫缺陷病毒(HIV)感染者最常见的机会性感染之一,并且是导致其死亡的主要原因。结核分枝杆菌能促进HIV复制,而HIV感染又是结核病发病的独立危险因素,并且可促使结核病由潜伏感染进展为活动性结核。本文着重介绍HIV合并结核分枝杆菌感染者结核病的诊断及其抗结核治疗进展。Mycobacterium tuberculosis infection is one of the most common opportunistic infection in human immunodeficiency virus（HIV）-infected patients,and is the main cause of death for HIV infected.Mycobacterium tuberculosis can enhance the replication of HIV,whereas HIV is an independent risk factor of tuberculosis which can urge tuberculosis from latent to active.This article focuses on the progress of the diagnosis and treatment for patients with HIV and mycobacterium tuberculosis co-infection.

关 键 词：人免疫缺陷病毒 结核分枝杆菌 诊断 治疗 

分 类 号：R512.91[医药卫生—内科学] R52[医药卫生—临床医学]